Volume | 186,249 |
|
|||||
News | - | ||||||
Day High | 0.50 | Low High |
|||||
Day Low | 0.47 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
FSD Pharma Inc | HUGE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.47 | 0.47 | 0.50 | 0.4799 | 0.4727 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
461 | 186,249 | $ 0.4795365 | $ 89,313 | - | 0.4184 - 1.6799 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:50:49 | formt | 742 | $ 0.4647 | USD |
FSD Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.48M | 38.50M | - | 0 | -23.61M | -0.61 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
FSD Pharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HUGE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.4597 | 0.5425 | 0.45 | 0.4760182 | 376,057 | 0.005 | 1.09% |
1 Month | 0.718 | 0.72 | 0.4184 | 0.5151872 | 179,236 | -0.2533 | -35.28% |
3 Months | 0.82 | 1.09 | 0.4184 | 0.7102887 | 175,673 | -0.3553 | -43.33% |
6 Months | 1.04 | 1.50 | 0.4184 | 0.8709675 | 138,993 | -0.5753 | -55.32% |
1 Year | 1.51 | 1.6799 | 0.4184 | 1.10 | 138,295 | -1.05 | -69.23% |
3 Years | 1.6296 | 2.25 | 0.4184 | 1.35 | 179,432 | -1.16 | -71.48% |
5 Years | 8.0497 | 14.00 | 0.4184 | 2.37 | 479,054 | -7.59 | -94.23% |
FSD Pharma Description
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting multiple sclerosis, LUCID-PSYCH, a psychoactive molecule targeting major depressive disorder, and FSD-PEA, an ultra-micronized palmitoyl ethylamine with a favorable safety profile targeting inflammation. |